Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years ; volume:16 ; number:1 ; day:31 ; month:3 ; year:2021 ; pages:1-10 ; date:12.2021
Orphanet journal of rare diseases ; 16, Heft 1 (31.3.2021), 1-10, 12.2021
- Creator
-
Vill, Katharina
Schwartz, Oliver
Blaschek, Astrid
Gläser, Dieter
Nennstiel-Ratzel, Uta
Wirth, Brunhilde
Burggraf, Siegfried
Röschinger, Wulf
Becker, Marc
Czibere, Ludwig
Durner, Jürgen
Eggermann, Katja
Olgemöller, Bernhard
Harms, Erik
Schara, Ulrike
Kölbel, Heike
Müller-Felber, Wolfgang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-021-01783-8
- URN
-
urn:nbn:de:101:1-2021051619292994560351
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vill, Katharina
- Schwartz, Oliver
- Blaschek, Astrid
- Gläser, Dieter
- Nennstiel-Ratzel, Uta
- Wirth, Brunhilde
- Burggraf, Siegfried
- Röschinger, Wulf
- Becker, Marc
- Czibere, Ludwig
- Durner, Jürgen
- Eggermann, Katja
- Olgemöller, Bernhard
- Harms, Erik
- Schara, Ulrike
- Kölbel, Heike
- Müller-Felber, Wolfgang
- SpringerLink (Online service)
Other Objects (12)
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
Spinal muscular atrophy
Postnatal management of preterm infants with spinal muscular atrophy: experience from German newborn screening
Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience
High-throughput screening reveals novel mutations in spinal muscular atrophy patients
Very severe spinal muscular atrophy (Type 0)
Why should a 5q spinal muscular atrophy neonatal screening program be started?
Disease burden of spinal muscular atrophy in Germany
Choosing Life with Spinal Muscular Atrophy Type 1
Therapeutic advances in 5q-linked spinal muscular atrophy
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
Spinal muscular atrophy
Postnatal management of preterm infants with spinal muscular atrophy: experience from German newborn screening
Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience
High-throughput screening reveals novel mutations in spinal muscular atrophy patients
Very severe spinal muscular atrophy (Type 0)
Why should a 5q spinal muscular atrophy neonatal screening program be started?
Disease burden of spinal muscular atrophy in Germany
Choosing Life with Spinal Muscular Atrophy Type 1
Therapeutic advances in 5q-linked spinal muscular atrophy
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
Spinal muscular atrophy
Postnatal management of preterm infants with spinal muscular atrophy: experience from German newborn screening
Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience
High-throughput screening reveals novel mutations in spinal muscular atrophy patients
Very severe spinal muscular atrophy (Type 0)
Why should a 5q spinal muscular atrophy neonatal screening program be started?
Disease burden of spinal muscular atrophy in Germany
Choosing Life with Spinal Muscular Atrophy Type 1